🔥🐔 BizChicken 🐔🔥
Companies Similar to Beam Therapeutics Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Gain Therapeutics, Inc.
Site-Directed Enzyme Enhancement Therapy platform
Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.
Symbol: GANX
Recent Price: $2.18
Industry: Biotechnology
CEO: Mr. Gene Mack M.B.A.
Sector: Healthcare
Employees: 29
Address: 4800 Montgomery Lane, Bethesda, MD 20814
Phone: 301 500 1556
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Sangamo Therapeutics, Inc.
ZFP Technology Platform
Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company that develops genomic medicines using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation with a focus on transforming patients' lives.
Contact | About | About | Leadership | Leadership | About | About | About | About | About | About | About | About | About | About | Careers | Vision/Values | DEI | Benefits | About | About | About | About | About | About | About | News | Events | Vision/Values | DEI | Benefits | Careers | Careers | About | About
Symbol: SGMO
Recent Price: $2.34
Industry: Biotechnology
CEO: Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Sector: Healthcare
Employees: 405
Address: 501 Canal Blvd, Brisbane California, CALIFORNIA 94005
Phone: 510 970 6000
Leadership
- Sandy Macrae, M.B., Ch.B., Ph.D.,
- Gregory Davis, Ph.D., Head of Research and Technology
- Nathalie Dubois-Stringfellow, Ph.D., Chief Development Officer
- Prathyusha Duraibabu, Chief Financial Officer
- Phillip Ramsey, Head of Technical Operations
- Stephanie J. Seiler, CLP, Head of Business Development & Alliance Management
- Louise Wilkie, Global Corporate Communications and Investor Relations
- Scott Willoughby, General Counsel and Corporate Secretary
- H. Stewart Parker, Chair of the Board
- Courtney Beers, Ph.D.,
- Robert Carey,
- Kenneth Hillan, M.B. Ch.B.,
- Margaret (Peg) A. Horn, J.D.,
- John Markels, Ph.D.,
- James R. Meyers,
- Karen Smith, M.D., Ph.D., M.B.A., LLM,
Last updated: 2024-12-31
Taysha Gene Therapies, Inc.
TSHA-120, TSHA-102, TSHA-121, TSHA-118, TSHA-105, TSHA-101
Taysha Gene Therapies, Inc. focuses on developing adeno-associated virus-based gene therapies for treating monogenic diseases of the central nervous system, with a pipeline including treatments for conditions such as giant axonal neuropathy, Rett syndrome, and GM2 gangliosidosis.
Symbol: TSHA
Recent Price: $1.73
Industry: Biotechnology
CEO: Mr. Sean P. Nolan
Sector: Healthcare
Employees: 52
Address: 3000 Pegasus Park Drive, Dallas, TX 75247
Phone: 214 612 0000
Last updated: 2024-12-31
Black Diamond Therapeutics, Inc.
BDTX-189, BDTX-1535, BDTX-4933
Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.
Symbol: BDTX
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Mark A. Velleca M.D., Ph.D.
Sector: Healthcare
Employees: 54
Address: One Main Street, Cambridge, MA 02142
Phone: 617 252 0848
Leadership
- Ali Behbahani, M.D., Co-Head of Healthcare, NEA
- Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
- Kapil Dhingra, M.D., Former Head, Roche Oncology Development
- Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
- Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
- Prakash Raman, Ph.D., CEO of InduPro, Inc.
- Mark A. Velleca, M.D., Ph.D., CEO and Board Chair
Last updated: 2024-12-31
Beam Therapeutics Inc.
precision genetic medicines
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States, with a focus on conditions such as sickle cell disease, beta thalassemia, and Glycogen Storage Disease Type Ia.
About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About | About | Careers | About | Jobs | Careers
Symbol: BEAM
Recent Price: $25.28
Industry: Biotechnology
CEO: Mr. John M. Evans M.B.A.
Sector: Healthcare
Employees: 472
Address: 238 Main Street, Cambridge, MA 02142
Phone: 857 327 8775
Last updated: 2024-12-31
BeiGene, Ltd.
BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy
Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.
About | About | Vision/Values | About | About | Culture | DEI | Culture | Leadership | About | Contact | Careers | Careers | Careers | Careers | About | About | About | About | About | Jobs | About | About | About
Symbol: BGNE
Recent Price: $183.81
Industry: Biotechnology
CEO: Mr. John V. Oyler
Sector: Healthcare
Employees: 10000
Address: 55 Cambridge Parkway, Cambridge, MA 02142
Phone: 781-801-1800
Leadership
- John V. Oyler, Co-Founder, Chairman and CEO
- Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
- Olivier Brandicourt, M.D., Director
- Margaret Dugan, M.D., Director
- Donald W. Glazer, Director
- Michael Goller, Director
- Anthony Hooper, Director
- Ranjeev Krishana, Director
- Michael Nuoqing Yi, Director
- Alessandro Riva, M.D., Director
- Corsee Sanders, Ph.D., Director
- Shalini Sharp, Director
- Steven Young, Ph.D., Acting Head of Medicinal Chemistry
- Ron Levy, M.D., Scientific Advisory Board
- Neal Rosen, M.D., Ph.D., Scientific Advisory Board
- Charles Sawyers, M.D., Scientific Advisory Board
- David Schenkein, M.D., Scientific Advisory Board
- Melika Davis, SVP & Global Head, Clinical Operations
- Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
- Tony Guo, Ph.D., SVP, Global Statistics & Data Science
- Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
- Graham Hardiman, Global Head of HR
- Shreya Devendra Jani, SVP, Corporate Affairs
- Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
- Yang Ji, Chief Compliance Officer
- Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
- Chan Lee, General Counsel
- Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
- Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
- Kyoung Lim, VP of Supply Chain
- Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
- Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
- Richard O’Keeffe, Head of Global Quality
- Jurij Petrin, M.D., Head of New Market Development
- Yan Qi, Ph.D., SVP, Head of Public Affairs
- Hongyu Qian, SVP, Medical Affairs
- Jason Radford, SVP, Strategy & Corporate Development
- Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
- Adam Roach, VP and Head of Asia Pacific
- Aaron Rosenberg, Chief Financial Officer
- Michael Schoen, Strategic Advisor and Special Assistant to the CEO
- Matt Shaulis, General Manager of North America
- Lai Wang, Ph.D., Global Head of R&D
- Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
- Beth Wensley, SVP, Head of Portfolio and Program Management
- Kimberly Wolf, SVP, Global Commercial Strategy & Operations
- Xiaobin Wu, Ph.D., President, Chief Operating Officer
- Eva Yin, Chief Commercial Officer, Greater China
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Precision BioSciences, Inc.
ARCUS
Precision Bio Sciences, Inc. is a clinical stage gene editing company specializing in in vivo gene editing and ex vivo allogeneic CAR T therapies, including the ARCUS genome editing platform and various investigational CAR T immunotherapies.
Contact | Careers | Careers | Careers | Careers | Leadership | Leadership | Leadership | Careers | Careers | About | About | About
Symbol: DTIL
Recent Price: $4.26
Industry: Biotechnology
CEO: Mr. Michael Amoroso
Sector: Healthcare
Employees: 109
Address: 302 East Pettigrew Street, Durham, NC 27701
Phone: 919 314 5512
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
Moderna, Inc.
messenger RNA therapeutics and vaccines
Moderna, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of messenger RNA therapeutics and vaccines for various diseases including infectious diseases and cancer. It operates globally with a range of vaccines targeting respiratory, latent, and public health viruses.
Vision/Values | Contact | Careers | Careers | Careers | Careers | About | Careers | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Awards | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Careers | Careers | About | About | About | About | About | News | About
Symbol: MRNA
Recent Price: $39.38
Industry: Biotechnology
CEO: Mr. Stephane Bancel
Sector: Healthcare
Employees: 5600
Address: 200 Technology Square, Cambridge, MA 02139
Phone: 617 714 6500
Last updated: 2024-12-31
Prime Medicine, Inc.
Prime Editors
Prime Medicine, Inc. is a biotechnology company focused on delivering genetic therapies using gene editing technology. Headquartered in Cambridge, Massachusetts, the company was founded in 2019.
About | About | About | Careers | Careers | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: PRME
Recent Price: $2.78
Industry: Biotechnology
CEO: Dr. Keith Michael Gottesdiener M.D., Ph.D.
Sector: Healthcare
Employees: 234
Address: 21 Erie Street, Cambridge, MA 02139
Phone: 617-564-0013
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
TScan Therapeutics, Inc.
T cell receptor-engineered T cell therapies
TScan Therapeutics, Inc. is a preclinical-stage biopharmaceutical company that develops T cell receptor-engineered T cell therapies for cancer treatment. It is working on therapies for hematologic malignancies and solid tumors, as well as vaccines for infectious diseases like SARS-CoV-2.
About | About | Management | Directors | About | About | Contact | Careers | Careers | Careers | About | About
Symbol: TCRX
Recent Price: $3.00
Industry: Biotechnology
CEO: Dr. Gavin MacBeath Ph.D.
Sector: Healthcare
Employees: 175
Address: 830 Winter Street, Waltham, MA 02451
Phone: 857 399 9500
Leadership
- Stephen Biggar, M.D., Ph.D., Partner at Baker Bros. Advisors LP
- Katina Dorton, J.D., M.B.A., CFO of Nodthera
- Gabriela Gruia, M.D., Chief Development Officer at Ichnos Sciences
- Barbara Klencke, M.D., Former Chief Medical Officer and Chief Development Officer of Sierra Oncology Inc.
- Gavin MacBeath, Ph.D., CEO of TSCAN
- Garry Nicholson, Former President of Pfizer Oncology
- R. Keith Woods, Former Chief Operating Officer of argenx
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31